Specifically, this protective effect of quercetin against atherosclerosis is partly attributed to its inhibition of phenotypic switch of VSMCs to macrophage-like cells and subsequent foam cell formation through a JAK2/STAT3/KLF4-dependent mechanism, providing a novel approach for attenuating atherosclerosis. The gene discussed is JAK2; the disease is atherosclerosis.